Regulation
Regulatory status
OptAxe Limited is authorised and regulated by the Financial Conduct Authority (firm reference number 1002237) to operate a multilateral trading facility. This page records the venue's status in each jurisdiction where participants are based, and links to the documents that govern it.
By jurisdiction
Where participants can access the venue
| Jurisdiction | Regulator | Status | Reference | Since |
|---|---|---|---|---|
| United Kingdom | FCA | Authorised to operate an MTF | FRN 1002237 | October 2024 |
| United States | CFTC | Eligible UK Facility under CFTC no-action relief; US participants may trade without the venue registering as a SEF | CFTC Letter 26-10; Appendix A of Staff Letter 24-11 | 24 March 2026 |
| Switzerland | FINMA | Recognised as a foreign trading venue (Art. 41 FinMIA) | FINMA decision, ref. G01577481; FINMA list of recognised foreign trading venues | 30 July 2026 |
| Canada (Ontario) | OSC | Exempted from recognition as an exchange | OSC exemption decision | 18 August 2026 |
| European Union | ESMA and national authorities | No EU-wide equivalence is in place for UK trading venues. Access for EU participants depends on the law of their member state, including where a participant approaches OptAxe at its own exclusive initiative | MiFID II Art. 42; national third-country regimes | 1 January 2021 |
Trading on a multilateral trading facility does not change a participant's status under EMIR, because an MTF is not a regulated market. Reporting and risk mitigation obligations continue to sit with the counterparties. How participants are classified under EMIR
Latest regulatory updates
OptAxe regulated updates
Code of conduct
Committed to the FX Global Code
OptAxe Limited has signed a Statement of Commitment to the FX Global Code, dated 22 January 2024. OptAxe acts as a Market Participant as defined by the Code and is committed to conducting its FX market activities in a manner consistent with the principles of the Code.
View the statement on the Disclosures pageView the signed statement on the CME Group public registerDisclosures and policies
The Rulebook, fee schedule, MIFIDPRU 8.6 remuneration disclosure and FX Global Code statement.
DisclosuresRemuneration disclosure (MIFIDPRU 8.6), PDF